Mumbai, India, November 5 (ots/PRNewswire) - - VMS to Improve Security and Ensure Compliance for Organizations Tata Communications, a leading provider of a new world of communications today announced the global availability of its Vulnerability Management Service (VMS) (http://www.tatacommunications.com/enterprise/security/cloud.asp.) Tata Communications' ...
Abbotsford, Canada, November 4 (ots/PRNewswire) - ICS Copper Systems Ltd. (ICX:TSX.V) announces that due to the reduction in copper prices over the last few months and current market conditions the Company has decided to suspend it's exploration activities and the completion of it's EMEW plant in Zambia as it undertakes a strategic review of operations. Mokambo Review To date the company has completed a first phase drilling programme on the Mokambo sulphide ...
Burcon NutraScience Corporation
Vancouver, Canada, November 4 (ots/PRNewswire) - Burcon NutraScience Corporation (TSX-V: BU) announces today that it has developed a revolutionary soy protein isolate. Burcon has branded this new soy protein isolate as CLARISOY(TM). CLARISOY(TM) is 100% soluble and transparent in acidic solutions, enabling applications down to pH 2.5. CLARISOY(TM) also ...
Mumbai, India, November 4 (ots/PRNewswire) - - South East Asia is a Key Focus for Network Expansion Tata Communications, a leading provider of the new world of communications, today announced the expansion of its global MPLS (Multi- Protocol Label Switching) services into key South - East Asian destinations, including the Philippines, Malaysia, Taiwan, and Thailand - providing rest of the world connectivity to ...
New York, November 3 (ots/PRNewswire) - - Asset Control's AC Plus Streamlines Data Capture and Standardizes Distribution Asset Control, a world-wide leader in financial data management solutions, today announced that Citadel Solutions LLC, a wholly-owned independent subsidiary of Citadel Investment Group, LLC, has implemented Asset Control's AC Plus data ...
Basel, Switzerland, November 1 (ots/PRNewswire) - - Three New Studies Presented at AASLD Demonstrate Efficacy and Safety of Extended Treatment in Non-Responders, Relapsers and Slow-Responders Cure rates for certain groups of difficult-to-treat hepatitis C patients can be improved significantly by ...
Basel, Switzerland, November 1 (ots/PRNewswire) - A new, independently-conducted study being presented at AASLD shows that PEGASYS(R) (peginterferon alfa-2a (40KD)) regimens result in higher cure rates for hepatitis C patients compared to regimens with another pegylated interferon.(1) Comparing Today's Standard Treatment Regimens: The Milan Safety Tolerability ...
Ingelheim, Germany (ots/PRNewswire) - - 1 in 10 Women Experience Distress Associated With the Most Common Form of Female Sexual Dysfunction, yet the Condition Remains Largely Under-Recognised and Under-Diagnosed - For non-US media only Results from the PRESIDE*(1) survey, the largest study assessing the prevalence of female sexual problems, show that ...
London (ots/PRNewswire) - LINK Financial ("LINK"), the leading European purchaser and servicer of performing and non-performing consumer receivables, today announces the formation of a GBP250 million partnership with one of the world's largest pension funds based in Europe. The agreement initially covers a co-investment in a portfolio of UK distressed loans that has been acquired by LINK from a global consumer lender ...
New York (ots/PRNewswire) - - Exclusive Agreement Set to Bring The Beatles Music to Fans for the First Time in Interactive Form Here, There and Everywhere in 2009 The Beatles' extraordinary music and phenomenal legacy is set to rock across the universe in the form of a video game through an exclusive ...
Hoofddorp, Netherlands (ots/PRNewswire) - CEVA Group Plc will release its Quarter 3 2008 results on November 4, 2008. The Interim Financial Statements will be published on CEVA's website (http://www.cevalogistics.com) at 09:00 Central European Time. A press release with the highlights of the Report will be issued on the same date. CEVA. Making Business Flow ...
Geneva, Switzerland (ots/PRNewswire) - - Merck Serono's US Affiliate EMD Serono, Inc. to Acquire Rights in Tesamorelin, a Phase 3 Compound Being Investigated for the Treatment of Excess Abdominal Fat in HIV Patients With Lipodystrophy in the US - Merck KGaA, Darmstadt, Germany, of Which Merck Serono is ...
Toronto, Canada (ots/PRNewswire) - - Ontario Biotech Companies Work Together on Innovative Bone Protein Technology TORONTO, Canada, October 28 /PRNewswire/ -- Thomas Wellner, President and CEO of Therapure BioPharma Inc. and Dr. Cameron Clokie, President and CEO of Induce Biologics Inc. today announced a development partnership utilizing an innovative ...
Pershing Square Capital Management, L.P.
New York (ots/PRNewswire) - Pershing Square Capital Management, L.P. announced today that it will host a public presentation on Wednesday, October 29, 2008 where it will detail a potential transaction that Pershing Square believes will build long-term value for Target Corporation (NYSE: TGT) and all of its ...
Rousset, France (ots/PRNewswire) - - Portable Design China Readers Voted the AT91SAM9G20 Best in Class for Performance and Performance & Functionality vs Cost Atmel(R) Corporation (Nasdaq: ATML) announced today that its 400 MHz AT91SAM9G20 ARM926EJ-S(TM)-based embedded microprocessor has been voted one of the five best microcontrollers by the 2008 ...
San Francisco (ots/PRNewswire) - - Game-Changing Initiative has Potential to Revolutionize ATS Market Seizing on the opportunity to help cash- and credit-strapped small and midsized businesses, MrTed Ltd., a recognized leader in talent acquisition solutions, today announced the beta availability of SmartRecruiters, a 100% free applicant tracking system (ATS) ...
Madrid, Spain (ots/PRNewswire) - -- The Expiration Date of the U.S. Offer has been extended until 12:00 midnight, New York City time, on October 31, 2008. Telefonica S.A. ("Telefonica") announced today that the U.S. Offer would be extended to 12:00 midnight, New York City time, on October 31, 2008. ...
Antony, France (ots/PRNewswire) - Stallergenes has just obtained authorization (IND(1)) from the FDA for immediately launching a phase III clinical trial in the United States with Oralair(R) Grasses in the treatment of allergic rhinoconjunctivitis to grass pollens in adults. The aim of the study, which will ...
Washington (ots/PRNewswire) - - Data presented at the joint annual meeting of ICAAC and IDSA - Results suggest candidate vaccine may be as effective as Prevnar for the seven shared serotypes, and provide expanded coverage for six additional serotypes - Wyeth on track to complete U.S. filing for ...
Rousset, France and Bellevue, Washington (ots/PRNewswire) - - From November 17 to November 21, 2008, in Dallas, TX, including free AT91SAM9261 evaluation kit. Atmel(R) Corporation (Nasdaq: ATML) and Adeneo announced today a Microsoft(R) Windows(R) Embedded CE(R) 6.0 Training Course in Dallas, TX from November 17 to November 21, 2008. This event is an ...
Boston (ots/PRNewswire) - - Virtually eliminates context switching and interrupt usage ESC Boston, MA, Booth Number 801 -- Atmel(R) Corporation (Nasdaq: ATML) announced today its latest family of 32 MIPS, picoPower(TM) 8/16-bit microcontroller that radically improves MCU performance by off-loading interrupts and data transfers to an on-chip event manager and ...
Maidenhead, England (ots/PRNewswire) - - Data From Another Study Supported the use of ENBREL for up to Five Years in Ankylosing Spondylitis Patients New safety and efficacy data for active ankylosing spondylitis (AS) patients treated with ENBREL(R) (etanercept) were presented at the American College of ...
Basel, Switzerland (ots/PRNewswire) - - MabThera Shown to be Effective and Well Tolerated Over the Long-Term A study(1) has shown that rheumatoid arthritis patients given multiple courses of MabThera experienced further improvements in their condition with each subsequent treatment course. The patients in ...
Toronto, Canada (ots/PRNewswire) - - Wins First Ever All-Female Championship Final Match with a Dramatic Throw of Scissors Beating Paper to Win $10,000 Grand Prize With Photo Local RPS talent prevailed when Monica Martinez, a jewelry store owner from Toronto who entered for fun, with no intention of winning, won match after match to eventually seize ...
Paris (ots/PRNewswire) - - GenOdyssee Has Received Notice of Allowance of European Patent Application Covering Its Core Natural Evolution Technology Invented in 2002, and Received Broad Product Applications Protection Rights to All Cytokine Families GenOdyssee (GO), a biotechnology company dedicated to ...
Paris (ots/PRNewswire) - - Sanofi-aventis Will Comply With the European Authorities Request to Temporarily Suspend the Marketing Authorisation of Acomplia(R) in Obese and Overweight Patients and Will Make Every Effort to Actively Support Patients and Health Care Professionals in This Process. - ...
Beijing (ots/PRNewswire) - New results from the landmark ONTARGET(R) Trial show that, in Asian patients at high risk of cardiovascular disease (CVD), telmisartan (MICARDIS(R)) 80mg is as effective as, and significantly better tolerated than, ramipril 10mg in reducing the risk of cardiovascular death, heart ...
San Jose, California (ots/PRNewswire) - - New Product Line also Includes First to Market Single Layer ITO Touchscreen Solutions for Single Touch Applications Atmel(R) Corporation (Nasdaq: ATML) today announced its new line of charge-transfer, capacitive touchscreen controller ICs targeted at some of the ...
London (ots/PRNewswire) - In its efforts to improve safety for everyone, especially vulnerable road users, Honda's leading motorcycle to car communication system is being demonstrated for the first time in Europe at the CAR 2 CAR Communication Consortium event taking place at the Opel Test Track in Dudenhofen, Germany, from 22-23 October 2008. (Photo: http://www.newscom.com/cgi-bin/prnh/20081022/325797 ) The ...
Ingelheim, Germany (ots/PRNewswire) - - BI 6727, a Highly Potent and Selective Plk1 inhibitor, Represents Latest Advance in Company's Plk1 Programme - For non-US Healthcare Media Boehringer Ingelheim's most promising new cell cycle kinase inhibitor and potentially first-in-class compound, BI 6727, ...